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Abstract
Introduction. Buccal drug delivery has a number of advantages over oral administration: ease of application, good blood supply to the buccal 
mucosa, drug can enter the systemic circulation directly, avoiding the "first pass effect through the liver", and are not exposed to the acidic 
environment of the gastric juice and the destructive action of digestive enzymes. The use of interpolymer complexes (IPCs) makes it possible not 
only to ensure adhesion to the mucosal membranes of the oral cavity, but also to achieve a prolonged release of drugs.
Aim. Development of carriers based on interpolymer complexes using Carbopol® 971 NF (C971) and poly(2-ethyl-2-oxazoline) (POZ) of different 
molecular weights for buccal delivery of metformin (MF).
Materials and methods. The study of IPC adhesion was carried out using a TA.XTplus texture analyzer (Stable Micro Systems, UK); mucin compacts 
with a diameter of 13 mm were used as a substrate; these were prepared by compressing porcine gastric mucin powder using a manual hydraulic 
press for IR spectroscopy (PerkinElmer, USA) at a pressure of 2.45 MPa. The study of the swelling capacity was carried out by placing polymer 
matrices in an artificial saliva medium, with constant thermostating at a temperature of 37.0 ± 0.5 °C for 5 hours. The study of the release of MF from 
the matrices based on IPC was carried out using a DFZ II apparatus (Erweka, Germany) according to the Flow Through Cell method (USP IV) with 
cells for tablets (22.6 mm) and adaptors for ointments, creams and gels in a medium simulating saliva. The concentration of MF in the samples from 
the dissolution tests was determined with UV-spectrophotometry (Lambda, PerkinElmer, USA) at 232.8 nm.
Results and discussion. In a comparative study of the mucoadhesive properties of polymer samples, IPC compacts showed a mucoadhesion 
capacity comparable to that of poly(2-ethyl-2-oxazoline); at the same time, compacts from physical mixtures (PM) and C971 are inferior in terms 
of the separation force to IPC samples, however, POZes dissolve in an artificial saliva medium, that is, they are not suitable as dosage forms for 
buccal delivery. For 5 hours of the experiment to assess the swelling capacity, the IPC matrices did not change significantly, which can ensure their 
comfortable use as carriers for buccal delivery. When evaluating the release of metformin from polymer matrices (with weight ratio MF/IPC 1: 0.5), 
the most complete release (more than 90 %) is observed from both IPC matrices compared to matrices of PM and individual polymers.
Conclusion. Polycomplex matrix systems based on C971-POZ (50 kDa) and C971-POZ (500 kDa) are suitable for buccal delivery of metformin.
Keywords: interpolymer complexes, metformin, buccal delivery, polyoxazoline, adhesion.
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Резюме
Введение. Трансбуккальная доставка лекарственных веществ (ЛВ) имеет ряд преимуществ по сравнению с пероральным введением: 
удобство применения для пациента, хорошее кровоснабжение буккальной слизистой, ЛВ попадают непосредственно в системный 
кровоток, минуя «эффект первого прохождения через печень», а также не подвергаются воздействию кислой среды желудочного сока и 
разрушающего действия пищеварительных ферментов. Применение интерполимерных комплексов (ИПК) позволяет не только обеспечить 
адгезию к слизистым оболочкам ротовой полости, но и получить пролонгированное высвобождение ЛВ.
Цель. Разработка носителей на основе интерполимерных комплексов с участием Carbopol® 971 NF и поли(2-этил-2-оксазолина) разных 
молекулярных масс для трансбуккальной доставки метформина (МФ).
Материалы и методы. Исследование адгезии ИПК проводилось на анализаторе текстуры TA.XTplus (Stable Micro Systems, Великобритания), в 
качестве субстрата использовали компакты муцина диаметром 13 мм, полученные путем прессования на ручном гидравлическом прессе для 
ИК-спектроскопии (PerkinElmer, США) при давлении 2,45 MПа. Исследование набухающей способности проводили помещением полимерных 
матриц в среду искуственной слюны при постоянном термостатировании при температуре 37,0 ± 0,5 °C в течение 5 часов. Исследование 
высвобождения метформина из матриц на основе соответствующих ИПК производилось на приборе DFZ II (ERWEKA, Германия) по методу 
USP IV «Проточная ячейка» с использованием ячеек для таблеток (22,6 мм) и адаптеров для изучения высвобождения мягких лекарственных 
форм – ЛФ (мазей, кремов, гелей) в среде, имитирующей слюнную жидкость. Оценка количества высвободившегося МФ проводилась 
УФ-спектрофотометрически на приборе Lambda 25 (PerkinElmer, США) при длине волны 232,8 нм.
Результаты и обсуждение. При сравнительном исследовании мукоадгезивных свойств образцов полимеров компакты из ИПК показали 
сопоставимую с поли(2-этил-2-оксазолином (ПО) разных молекулярных масс (50 и 500 кДа) способность к мукоадгезии; в то же время 
компакты из физических смесей (ФС) полимеров и Carbopol® 971 NF (С971) уступают по показателю силы отрыва образцам ИПК, при этом 
ПО растворяются в среде искусственный слюны, то есть непригодны для трансбуккальных систем. За 5 часов эксперимента, по оценке 
набухающей способности, матрицы ИПК изменились незначительно, что может обеспечить их комфортное для пациента использование в 
качестве носителей для буккальной доставки. При оценке высвобождения ЛВ из матриц (при соотношении МФ/ИПК 1:0,5) наиболее полное 
высвобождение (более 90 %) происходит из обеих матриц ИПК по сравнению с матрицами ФС и индивидуальных полимеров.
Заключение. Поликомплексные матричные системы на основе C971-ПО 50 кДа, C971-ПО 500 кДа являются подходящими для 
трансбуккальной доставки метформина. 
Ключевые слова: интерполимерные комплексы, метформин, трансбуккальная доставка, Carbopol® 971 NF, полиоксазолины, адгезия.
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INTRODUCTION
Buccal drug delivery has a number of advantages 
over oral administration: convenient use, a dosage form 
fixes not only painlessly but also does not cause dis-
comfort in the event of adverse reaction. Moreover, the 
buccal mucosa is characterized with a good blood sup-
ply, and any drug substance can enter the systemic cir-
culation directly avoiding the "first pass effect in the li- 
ver", and is not exposed to the acidic environment of 
the gastric juice and the destructive action of digestive 
enzymes. [1, 2].
For many decades, the mucoadhesive properties of 
polymers of synthetic and natural origin have been inves-
tigated. One of the variants for enhancing adhesion pro- 
perties of dosage forms was the combination of chemical-
ly complementary types of macromolecules with the for-
mation of interpolymer complexes (IPC), which have been 
also successfully proven as carriers in bioadhesive drug 
delivery systems [3, 4]. The group of Japanese investiga-
tors led by Nagai [5, 6] was the first to prove the prospec-
tiveness of the field, they showed the prospectiveness 
of IPCs derived with combination of rare crosslinked po- 
lyacrylic acid (carboxyvinyl polymer, carbomer, Car-
bopol®) with hydroxypropylcellulose [5] or polyvi-
nylpyrrolidone [6] by formation of macromolecular hydro-
gen chains between them.
Earlier, our research team had investigated the mu-
coadhesive properties of interpolyelectrolyte complexes 
(IPEC) formed by polyanions (Carbopol ® (71g NF, 2020 NF, 
10 Ultrez), Noveon® AA-1) and oppositely charged poly-
cations (Eudragit® EPO, chitosan – CTT A system for gast-
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roretentive delivery of metronidazole based on Eudragit ® 
copolymers was developed [11]. 
We also offered the system for transbuccal metro-
nidazole delivery based on Noveon AA-1 and Eudragit® 
EPO  [12]. As well, we had earlier produced and charac-
terized IPCs based on S971/PO, and well, diffusive and 
transport properties were examined on the example of 
generation of a polycomplex matrix system of mesalazin 
delivery to the large intestine [13].
The flow chart of the interpolymer reaction between 
the tested polymers was shown in figure 1.
The aim of the work was to investigate the appli-
cability of IPCs with Carbopol® 971 NF (proton-donor 
polymer) and poly(2-ethyl-2-oxazolin) (proton-acceptor 
polymer) of different molecular weights as new mucoad-
hesive carriers for transbuccal delivery of hypoglycemic 
drug substance – metformin. 
MATERIALS AND METHODS
Poly(2-ethyl-2-oxazolin) of various molecular weights 
(PO 50 kDa and PO 500 kDa) was purchased from com-
pany Sigma-Aldrich (Great Britain). Carbopol® 971 NF 
(rare crosslinked, 4000–11000 cP, 3000 kDa) (C971) was 
kindly provided by the Lubrizol Advanced Materials, Inc. 
(USA).
Polymers were used after being dried under a va- 
cuum at temperature 40  °C for 2 days. As a simulator, 
metformin (Sigma-Aldrich, Belgium) was used. For an 
investigation of bioadhesive properties mucin isolated 
from pig stomachs (type II) was used (Sigma-Aldrich, 
USA).
IPCs based on S971iPO50kDaiPO 500 kDA were pro-
duced with ratio 1.25 : 1 (by molls), predominant car-
bopol at рН 4.5 and 4.3 for poly(2-ethyl-2-oxazolin) with 
a molecular weight of 50 and 500 kDa, respectively, 
using the method described earlier [13].
Mucoadhesion of polycomplex matrixes was investiga- 
ted on texture analyzer TA.XTplus (Stable Micro Systems, 
Great Britain); as a substrate, we used mucin compacts pro-
duced by compression on a manual hydraulic press for 
IR-spectroscopy (PerkinElmer, USA), using the compressor 
13 mm in diameter (PIKE Technologies, USA) with pressure of 
2.45 MPas for 10 seconds. 
For an investigation of mucoadhesion and deter-
mination of swelling degree, plano-cylindrical tab-
lets were prepared from a polymeric carrier 100 mg by 
compression of the assigned amount of powders (S971, 
PO 50 kDa, PO 500 kDa, their PSs and polycomplexes 
based on C971-PO 50 kDa, C971-PO 500 kDa) on a ma- 
nual hydraulic press, similarly to the description gi- 
ven above. Swelling ability was investigated by placing 
polymeric matrixes to baskets (from device USP I) 
which were immersed to thermostate IC control eco 
18c (IKA® Werke GmbH, Germany) at 37.0 ± 0.5  °C. The 
volume of the artificial saliva medium with рН = 7.0 
prepared by the method [14], was 40 ml. The baskets 
were withdrawn from the medium every 15 minutes 
within the first hour, and then every 30 minutes; bas-
kets with tablets were dried carefully with filter paper 
and weighed. Swelling degree (%H) was calculated by 
the following equation:
%H = (m2 – m1/m1) × 100,
where m1 is the weight of a dry sample; m2 is the weight 
of a swelled sample.
The study of MF release from matrixes based on cor-
responding IPCs was performed on device DFZ II device 
(ERWEKA, Germany) with the USP 4 method ("a flow cell") 
in the closed cycle using special testing adapters for soft 
dosage forms (ointments, creams, gels) in the medium 
imitating salivary liquid. MF concentration in test frac-
tions withdrawn by the collector was determined within 
Figure 1. Scheme of formation of interpolymer complexes based on Carbopol® 971 NF and poly(2-ethyl-2-oxazoline)
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5 hours at laminar stream rate generated with addition of 
glass beads 1 mm in dimension in a cell, 4 ml/min., close to 
the rate of salivary fluid delivered in a human’s mouth [1, 
15]. The matrixes containing mixture of polymeric the 
carrier and MF in the ratio 0.5 : 1 (by weight), with a 
diameter of 13 mm were tabletted on a manual hydrau-
lic press for IR-spectroscopy (PerkinElmer, the USA) under 
the same conditions as for determination of mucoadhe-
sion and investigation of swelling process. The quantity 
of the released drug substance was evaluated with UV- 
spectroscopy on device Lambda 25e (PerkinElmer, USA) 
at the wavelength of 232.8 nm. 
RESULTS AND DISCUSSION
Despite the fact that group of polymers of poly 
(2-ethyl-2-oxazoline) type was first described in 1960, 
their intensive investigations have been performed in 
the current decade [16]. As it turned out, PO have ap-
peared be non-toxic, biocompatible and bio-inert no-
nionic polymers which made them very promising ma-
terials for biomedical use, qualified as an alternative to 
polyethylene glycols which are widely used for this pur-
pose [17]. Despite the PO efficacy, so far there are on-
ly few investigations on their possible use in pharma-
ceutical technology, and in particular in drug delivery 
systems [18–20]. 
Perhaps, the recent publication by Ruiz-Rubioidr 
was the closest to the purpose of our investigation [14], 
in which the authors studied the interaction of two 
carbopol types (Carbopol® 971 and 974) with PO and 
showed the prospectiveness of IPCs used as carriers 
for buccal hydrocortisone delivery. As a model for mu-
coadhesion investigation studying, the authors used the 
isolated pig buccal tissues and also the standard disso-
lution method "Rotating paddle" (USP II) used in most 
cases in studies of drug substance release from the buc-
cal systems [21–26]. 
The systemic analysis of publications on the selection 
of the method as close as possible to the actual condi-
tions for application of transbuccal dosage forms showed 
that four main variants with pharmacopoeial devices are 
used in the DS release test: the method already men-
tioned above with "Rotating paddle" (USP II) with a tab-
let placed to the surface of the dissolution medium [27]; 
the modified USP II method differing by the fact that buc-
cal system has one surface limited to an impenetrable 
membrane, and another one is fixed by cianoacrylate 
glue to the glass of 2 x 2 cm in size transferred in the 
dissolution medium; the third – the modified USP I me- 
thod according to the Italian Pharmacopeia, Farmaco-
pea Ufficiale XI Ed. (F.U.XI)] using a core (a basket holder) 
on which lower platform instead of a basket the tablet is 
fixed, which surface which has been moistened with 50 µl 
of the artificial salivary fluid, and after 2 minutes, after a 
vessel is filled with the dissolution medium, a release pro-
cess begins [28]; and the fourth – "Flow cell" method (USP 
IV) in "open cycle" configuration with large cells used for 
tablets (22.6  mm) and the minimum flow rate providing 
the artificial salivary liquid with minimum possible rate 
of 2–4 ml/min. [29]. In addition, the Chinese researchers 
have described and patented the system developed 
especially for investigation of release process from the 
buccal DF underlying the device which scheme and the 
principle of work are very similar to the vertical Franz cell 
with the only difference that it is a flow cell, and a DF is 
fixed on the top cover opening thus only one of the sys-
tem surfaces for DS release [30]. 
Analyzing the variants described in the literature, 
we have considered it appropriate to combine the prin-
ciple underlying the device of the Chinese scientists, 
and one of the adapters which is presented in a wide 
variety by producers of "Flow cell" devices (ERWEKA, 
Germany; Sotax AG, Switzerland) and recommended 
by American, European, British and other pharmaco-
peias in investigations of corresponding DFs. For this 
reason, we were interested in the adapter for release 
investigations from soft DFs (ointments, creams, gels) 
which use allows, on the one hand, to provide predo- 
minant involvement of one of the surfaces of the de-
livery system in the release process but, on the 
other hand – constancy of laminar inflow of the disso-
lution medium with a low speed from the bottom DF 
side that, in our opinion, brings closer these condi-
tions to natural conditions of salivary liquid inflow in 
the mouth to a buccal tablet. In this regard, it seemed 
interesting to us to estimate the variant offered in the 
study as the additional method allowing to evaluate DS 
release from the transbuccal delivery system. 
As it is known that one of important properties of 
the polymeric carrier for transbuccal delivery is swel- 
ling ability and the marked mucoadhesive properties 
to get a prolonged release of DS when the system is 
used [1, 2].
For evaluation of mucoadhesion of test polymers to 
the mucosa, we used the method based on the detach-
ment force measurement [31]. For mucoadhesion eval-
uation, we had previously moistened a mucin compact 
with the solution simulating the salivary fluid for forma-
tion of a superficial gel layer. Then the test sample was 
smoothly pressed with force of 0.1 N for 60 seconds, then 
the matrix was detached from the mucin compact to the 
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Figure 2 presented the results of detachment force 
measurements of the test samples. During the compara-
tive study of mucoadhesive properties of polymer samp- 
les, IPC compacts showed mucoadhesion ability compa-
rable to the one of poly (2-ethyl-2-oxazoline) samples; 
meanwhile, compacts from physical mixtures and C971 
are inferior to IPC samples in detachment force value. It 
was shown that detachment force of IPC C971-PO sample 
50 kDa exceeded a value of a pharmaceutical substance 
with the similar composition almost twice that indica- 
ted better mucoadhesive ability of a polycomplex. The li- 
near correlation was shown not in all samples, however 
despite the highest detachment force values of compacts 
based on poly(2-ethyl-2-oxazoline), this compact type 
was not suitable for the transbuccal prolonged delivery 
as POs of both molecular weights rapidly dissolved in the 
medium simulating the salivary fluid. 
It should be noted that our study results on the de-
tachment of individual polymers from the surface of mu-
cin compacts contradicted the working data presen- 
ted in [14], as well as conventional concepts of polymer 
charge effect on mucoadhesive properties. Polyelectro-
lytes generally exhibit more pronounced mucoadhe-
sive properties than non-ionic polymers  [2]. In our case, 
samples based on non-ionic poly(2-ethyl-2-oxazolines) 
have shown a more pronounced adhesion ability com-
pared to samples based on anionic S971. This difference 
is likely due to the use of mucin compacts rather than 
the actual buccal tissue of animals as a model substrate. 
The compacts being swelled may form a highly porous 
gel that promotes the penetration of macromolecules of 
linear poly(2-ethyl-2-oxazolines) to a greater extent than 
the rare crosslinked C971, the diffusion ability of which is 
strongly suppressed.
Diffusion transport properties of the matrices were 
evaluated in the medium simulating the salivary fluid. 
Figure 3 presents photos of matrix swelling in the me-
dium of artificial salivary fluid. Over 5  hours, polycom-
plex matrices changed slightly compared to PS and S971 
which can provide their patient-friendly use as carriers for 
buccal delivery. 
Based on the swelling profiles of the matrices (fi- 
gure 4), we may state that the matrices based on the 
PO 50  kDa, 500 kDa dissolve during the first hour of 
the experiment. All other samples of the test matrices 
passed the tests and did not break down within 5 hours 































Figure 2. Results of measuring the detachment force F (N  – 
Newton) of individual polymers (C971, POZ 50 kDa, 500 kDa), 
their physical mixtures and polycomplexes (C971-POZ 50 kDa, 
C971-POZ 500 kDa) from mucin compacts
Figure 3. Comparative characteristics of individual polymers, 
their physical mixtures and IPC in the process of swelling in an 
















С 971 POZ 50 kDa POZ 500 kDa
IPC (POZ 500 kDa) IPC (POZ 50 kDa) PM 1.25:1 (POZ 50 kDa)
PM 1.25:1 (POZ 500 kDa)
Figure 4. Comparative characteristics of swelling profiles in a 
medium simulating salivary fluid
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has a higher swelling ability exceeding IPC and PS 
samples in 3 times. In contrast, carbopol matrices are 
characterized with the presence of a pronounced core 
and a transparent hydrogel layer around due to hyd- 
ration of the ionized carboxyl groups of the rare 
crosslinked polymer [9, 10].
The next stage of the evaluation of diffusion trans-
port properties was to investigate the release rate of 
hydrophilic drug substance – metformin from matrices 
based on individual polymers, their pharmaceutical sub-
stances and polycomplexes in the medium simulating the 
salivary fluid with USP IV method ("Flow cell") using spe-
cial test adapters for soft DFs (ointments, creams, gels). 
When selecting them as a model of buccal application, 
we relied not only on formation of hydrogel structures 
in the swelling process of the tested matrices (figure 3), 
but also on the obvious proximity to the actual applica-
tion conditions simulating the continuous flow of artificial 
salivary fluid to the buccal tablet located on top of the 
adapter (figure 5).
As shown in figures 6 and 7, the drug substance 
release begins from the immersion of the samples to 
the medium, is increased throughout the test time and 
reaches the maximum by the end of the experiment. 
It can be stated that the greatest release (more than 
90 %) with the maximum MF release value reached at 
2 hours followed by the achieved concentration main-
tained at a constant level for additional 3 test hours, 
occurs from both IPC matrices, regardless of their mo-
lecular weights compared to PS matrices and indivi- 
dual polymers. 
The tested diffusion transport properties of tableted 
matrices in the medium simulating the saliva show the 
prospectiveness of S971-based PKI and PO used as car- 
riers for buccal delivery. However, despite the compara-
ble swelling ability and the pronounced mucoadhesive 
properties of the polycomplex matrices being compared, 
only IPC compacts 50 kDa PKI do not almost increase in 
size, which, given the cost-effective availability of PO 
50 kDa, makes the carrier more preferable for the use in 
metformin transbuccal delivery systems. 
CONCLUSION
During the comparative study of mucoadhesive 
properties of polymers samples, compacts of IPC C971-
PO 50 kDa, S971-PO 500 kDa have shown mucoadhesive 
ability comparable to the one of poly(2-ethyl-2-oxazo-
line). When evaluating the swelling capacity, the poly-
complex matrices have changed slightly compared to 
physical mixtures of individual polymers and carbopol 
which can provide their patient-friendly use as buccal 
delivery carriers. When evaluating metformin release 
with the proposed "flow cell" method using special 
Figure 5. Flow-through cell made by ERWEKA (Germany) for oral 
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Figure 6. Comparative characteristics of the release profiles 
of metformin from matrices based on C971, POZ 500 kDa, IPC 
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Figure 7. Comparative characteristics of the release profiles 
of metformin from matrices based on C971, POZ 50 kDa, IPC 
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test adapters for soft DFs (ointments, creams, gels), the 
greatest release (more than 90 %) is found in both poly-
complex matrices compared to the matrices of physi- 
cal mixtures and individual polymers. The proposed 
version allows to evaluate the release of drug substan- 
ces in the conditions adequately close to natural func- 
tioning conditions of transbuccal delivery systems. 
Based on the combination of the tested properties, IPC 
C971-PO 50 kDA is recommended as perspective for fur-
ther studies as a carrier for buccal tablets.
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